Your search for tofacitinib returned 2 results

Modest reduction seen in DAS28-CPR at 3 months for those receiving TOF vs ADA, but no difference seen at 9 months.

Researchers analyzed baseline and week 12 predictors of early response to mirikizumab to determine clinical outcomes by week 52.